Evidence map›Paper›PMID 26435771›Full record

ReviewWorld journal of stem cells2015

Stem cells: An eventual treatment option for heart diseases.

Joseph C Bilgimol, Subbareddy Ragupathi, Lakshmanan Vengadassalapathy, Nathan S Senthil, Kalimuthu Selvakumar, M Ganesan, Sadananda Rao Manjunath

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in World journal of stem cells, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Scientific Papers and Patents on Substances with Unproven Effects. Part 2.Recent patents on drug delivery & formulation · 2019
    Review
  2. The transplantation of induced pluripotent stem cells into the cochleae of mature mice.International journal of clinical and experimental pathology · 2018
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Joseph C BilgimolJoseph C Bilgimol, M Ganesan, Sadananda Rao Manjunath, Micro Therapeutic Research Labs Private Limited, Chennai 600059, Tamilnadu, India.
Subbareddy RagupathiJoseph C Bilgimol, M Ganesan, Sadananda Rao Manjunath, Micro Therapeutic Research Labs Private Limited, Chennai 600059, Tamilnadu, India.
Lakshmanan VengadassalapathyJoseph C Bilgimol, M Ganesan, Sadananda Rao Manjunath, Micro Therapeutic Research Labs Private Limited, Chennai 600059, Tamilnadu, India.
Nathan S SenthilJoseph C Bilgimol, M Ganesan, Sadananda Rao Manjunath, Micro Therapeutic Research Labs Private Limited, Chennai 600059, Tamilnadu, India.
Kalimuthu SelvakumarJoseph C Bilgimol, M Ganesan, Sadananda Rao Manjunath, Micro Therapeutic Research Labs Private Limited, Chennai 600059, Tamilnadu, India.
M GanesanJoseph C Bilgimol, M Ganesan, Sadananda Rao Manjunath, Micro Therapeutic Research Labs Private Limited, Chennai 600059, Tamilnadu, India.
Sadananda Rao ManjunathJoseph C Bilgimol, M Ganesan, Sadananda Rao Manjunath, Micro Therapeutic Research Labs Private Limited, Chennai 600059, Tamilnadu, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stem cells are of global excitement for various diseases including heart diseases. It is worth to understand the mechanism or role of stem cells in the treatment of heart failure. Bone marrow derived stem cells are commonly practiced with an aim to improve the function of the heart. The majority of studies have been conducted with acute myocardial infarction and a few has been investigated with the use of stem cells for treating chronic or dilated cardiomyopathy. Heterogeneity in the treated group using stem cells has greatly emerged. Ever increasing demand for any alternative made is of at most priority for cardiomyopathy. Stem cells are of top priority with the current impact that has generated among physicians. However, meticulous selection of proper source is required since redundancy is clearly evident with the present survey. This review focuses on the methods adopted using stem cells for heart diseases and outcomes that are generated so far with an idea to determine the best therapeutic possibility in order to fulfill the present demand.

Indexed as

Bone marrow stem cellsHeart diseasesInduced pluripotent stem cellsMesenchymal stem cellsProgenitor cellsStem cells

Identifiers

PMID26435771
PMCPMC4591785

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.